WallStreetZenWallStreetZen

Sectors & IndustriesHealthcareDiagnostics & Research
Best Diagnostic & Research Stocks to Buy Now (2024)
Top diagnostic & research stocks in 2024 ranked by overall Zen Score. See the best diagnostic & research stocks to buy now, according to analyst forecasts for the diagnostics & research industry.

Industry: Diagnostics & Research
Ticker
Company
Price
Valuation Score
Graham Fair Value
Graham Fair Value %
P/E
Forward P/E
P/S
P/B
PEG
Free Cash Flow
Free Cash Flow Yield
Book Value
BVPS
EV
EV/EBITDA
FONR
FONAR CORP
$17.61N/AN/A9.32xN/A1.11x0.72xN/A$12.25M10.80%$163.89M25.46$100.78M3.91
ICLR
ICON PLC
$315.14$137.85128.61%37.97x21.63x3.16x2.76x1.20x$1.17B4.50%$9.43B114.23$29.31B18.08
STRR
STAR EQUITY HOLDINGS INC
$0.92$22.88-95.98%0.57xN/A0.31x0.22x0.02x$3.23M22.50%$65.30M4.18-$756.65k-0.03
RVTY
REVVITY INC
$102.82$68.8549.34%18.49x14.88x4.62x1.61x0.94x$9.90M0.08%$7.87B63.73$15.82B12.70
CRL
CHARLES RIVER LABORATORIES INTERNATIONAL INC
$235.27$189.5824.10%25.38x16.21x2.92x3.36x0.59x$365.37M3.03%$3.60B70.22$14.87B14.49
NEOG
NEOGEN CORP
$12.14$3.43254.14%607.00x19.27x2.83x0.84x1.28x-$12.98M-0.49%$3.15B14.53$3.36B17.79
TMO
THERMO FISHER SCIENTIFIC INC
$573.55$366.2556.60%36.65x21.18x5.16x4.81x0.72x$7.65B3.49%$45.52B119.15$249.04B21.90
IDXX
IDEXX LABORATORIES INC
$476.87$84.40465.00%45.72x43.00x10.64x25.10x6.15x$796.79M2.01%$1.57B18.88$40.04B32.24
ENZ
ENZO BIOCHEM INC
$1.07$23.75-95.49%1.60xN/A4.21x0.77x0.02x-$45.92M-84.95%$70.78M1.40$1.68M0.05
DGX
QUEST DIAGNOSTICS INC
$135.64$80.4068.70%18.01x15.38x1.62x2.34x1.22x$947.00M6.29%$6.43B57.95$19.95B11.71
QGEN
QIAGEN NV
$42.58$21.5098.01%29.01x17.07x4.92x2.65x1.11x$367.58M3.86%$3.60B16.08$10.52B15.47
SHC
SOTERA HEALTH CO
$11.29$30.53-63.02%59.42x9.18x2.96x7.44x0.13x-$376.77M-11.83%$429.39M1.52$5.28B12.39
A
AGILENT TECHNOLOGIES INC
$140.61$70.9698.16%33.32x23.40x6.12x6.66x1.03x$1.65B4.00%$6.19B21.12$42.01B24.86
DHR
DANAHER CORP
$247.40$151.7463.04%41.51x21.20x8.14x3.43x0.73x$5.57B3.04%$53.44B72.16$194.38B25.79
MEDP
MEDPACE HOLDINGS INC
$400.74$56.17613.46%39.40x54.90x6.30x18.49x401.13x$473.34M3.83%$671.54M21.77$12.15B29.92
FLGT
FULGENT GENETICS INC
$21.49N/AN/A-3.86x-27.91x2.22x0.57xN/A$18.78M2.94%$1.13B37.96$588.81M-4.61
WAT
WATERS CORP
$319.86$161.4198.16%29.43x21.94x6.39x16.46x1.10x$442.18M2.34%$1.15B19.47$20.98B20.96
LH
LABORATORY CORP OF AMERICA HOLDINGS
$201.04$230.88-12.92%39.42x10.06x1.38x2.13x0.35x$683.20M4.03%$7.96B94.43$22.82B14.69
SERA
SERA PROGNOSTICS INC
$9.92N/AN/A-8.55xN/A992.00x4.58xN/A-$27.01M-8.73%$70.16M2.25$319.06M-9.18
PRE
PRENETICS GLOBAL LTD
$5.78N/AN/A-1.04xN/A3.25x0.34xN/A-$13.43M-19.05%$206.36M16.91$27.21M-0.49
CSTL
CASTLE BIOSCIENCES INC
$24.41N/AN/A-21.41x-11.25x2.68x1.67xN/A-$6.44M-0.96%$402.46M14.64$616.00M-34.48
IQV
IQVIA HOLDINGS INC
$227.04$118.6391.39%30.60x18.70x2.74x6.52x1.02x$1.62B3.93%$6.34B34.88$53.66B16.42
PSNL
PERSONALIS INC
$1.59N/AN/A-0.71x-0.73x1.04x0.62xN/A-$67.17M-87.67%$129.44M2.69$61.64M-0.65
PRPO
PRECIPIO INC
$5.98N/AN/A-1.33xN/A0.51x0.59xN/A-$3.69M-47.49%$14.43M11.12$8.16M-1.89
NTRA
NATERA INC
$97.21N/AN/A-25.72x-30.86x10.33x15.34xN/A-$286.15M-2.56%$765.33M6.66$11.53B-30.08
MTD
METTLER TOLEDO INTERNATIONAL INC
$1,250.80$534.83133.87%34.65x25.86x7.21x-179.18x1.30x$861.39M3.15%-$149.94M-6.86$28.88B24.63
DRIO
DARIOHEALTH CORP
$1.60N/AN/A-0.83x-0.82x2.23x0.81xN/A-$30.96M-68.19%$58.14M2.05$39.85M-0.73
OLK
OLINK HOLDING AB (PUBL)
$23.15N/AN/A-92.60x463.00x16.97x5.73xN/A-$48.97M-1.70%$502.70M4.04$2.78B-138.89
ACRS
ACLARIS THERAPEUTICS INC
$1.31N/AN/A-1.03x-0.82x2.92x0.59xN/A-$79.63M-87.10%$157.18M2.25$53.46M-0.61
STIM
NEURONETICS INC
$3.75N/AN/A-3.57x-4.36x1.51x3.26xN/A-$34.41M-32.03%$34.19M1.19$114.38M-5.03
DMTK
DERMTECH INC
$0.63N/AN/A-0.20x-0.19x1.34x0.38xN/A-$77.88M-380.54%$57.18M1.75$35.89M-0.38
NEO
NEOGENOMICS INC
$15.51N/AN/A-23.50x-31.02x3.20x2.15xN/A-$39.59M-2.02%$923.41M7.32$2.26B1,702.17
TWST
TWIST BIOSCIENCE CORP
$44.67N/AN/A-13.29x-11.94x9.30x4.64xN/A-$95.52M-3.70%$560.13M9.69$2.45B-15.76
EXAS
EXACT SCIENCES CORP
$63.35N/AN/A-56.06x-28.03x4.57x3.66xN/A$31.93M0.28%$3.15B17.46$13.45B257.65
OCX
ONCOCYTE CORP
$2.77N/AN/A-0.74x0.99x14.13x1.12xN/A-$23.25M-109.71%$20.47M2.68$14.65M-0.56
BNR
BURNING ROCK BIOTECH LTD
$0.81N/AN/A-0.92x-1.07x1.12x0.78xN/A-$36.49M-43.79%$106.28M1.04-$103.47k0.00
BGLC
BIONEXUS GENE LAB CORP
$0.60N/AN/A-3.25xN/A0.97x1.09xN/A-$1.45M-15.29%$9.66M0.61$8.03M-3.23
RDNT
RADNET INC
$52.00$13.88274.55%1,040.00x98.11x2.05x5.65x1.34x$44.35M1.34%$630.70M9.92$4.71B17.74
APDN
APPLIED DNA SCIENCES INC
$3.63N/AN/A-0.33x0.05x0.28x0.73xN/A-$7.67M-309.09%$4.23M6.19$89.91k-0.02
LAB
STANDARD BIOTOOLS INC
$2.48N/AN/A-2.64xN/A1.85x-4.86xN/A-$46.12M-23.51%-$148.05M-1.87$766.00M-11.67
GH
GUARDANT HEALTH INC
$19.10N/AN/A-4.46x-3.78x3.79x14.65xN/A-$345.46M-16.15%$158.68M1.42$2.52B-5.81
XGN
EXAGEN INC
$1.38N/AN/A-1.03x-1.02x0.46x1.05xN/A-$15.27M-62.54%$22.69M1.28$10.52M-0.58
XWEL
XWELL INC
$1.80N/AN/A-0.27xN/A0.25x0.58xN/A-$17.98M-239.22%$13.00M3.11$9.44M-0.39
BDSX
BIODESIX INC
$1.52N/AN/A-2.38x-3.30x2.54x32.17xN/A-$45.93M-36.78%$4.58M0.06$181.76M-4.90
CDNA
CAREDX INC
$10.18N/AN/A-2.88x-19.21x1.95x2.02xN/A-$26.73M-4.88%$261.33M4.86$472.60M-2.59
ME
23ANDME HOLDING CO
$0.49N/AN/A-0.44xN/A0.94x0.62xN/A-$194.26M-82.96%$377.19M0.78$70.19M-0.14
CHEK
CHECK-CAP LTD
$2.20N/AN/A-0.73x-0.92xN/A0.47xN/A-$17.74M-137.57%$27.40M4.68$9.41M-0.49
ULS
UL SOLUTIONS INC
$36.07N/AN/A27.75xN/A2.69xN/AN/A$252.00M3.49%$654.00M3.27N/AN/A
PRPH
PROPHASE LABS INC
$5.34N/AN/A-5.45x6.85x2.07x1.95xN/A-$14.46M-15.73%$49.38M2.87$115.59M-7.80
OPK
OPKO HEALTH INC
$1.32N/AN/A-5.28x-11.00x1.15x0.66xN/A-$41.76M-4.24%$1.39B1.85$1.13B-17.26
AWH
ASPIRA WOMEN's HEALTH INC
$3.21N/AN/A-1.77x-0.52x3.24x-16.75xN/A-$15.92M-53.71%-$2.37M-0.26$39.62M-2.40
NDRA
ENDRA LIFE SCIENCES INC
$0.32N/AN/A-0.20xN/AN/A0.63xN/A-$9.57M-465.63%$5.66M0.89$1.13M-0.11
NOTV
INOTIV INC
$4.77N/AN/A-3.67xN/A0.21x0.48xN/A$6.48M5.26%$254.16M9.87$529.54M8.89
VNRX
VOLITIONRX LTD
$0.78N/AN/A-1.56xN/A70.82x-8.19xN/A-$19.15M-34.53%-$7.80M-0.11$49.06M-1.46
MDXH
MDXHEALTH SA
$3.13N/AN/A-0.23x-2.46x0.11x-8.78xN/A-$24.92M-291.82%-$973.00k-0.36$101.75M-4.76
MYGN
MYRIAD GENETICS INC
$19.97N/AN/A-6.28xN/A2.20x2.29xN/A-$184.20M-11.14%$783.20M9.46$1.81B-9.75
GENE
GENETIC TECHNOLOGIES LTD
$2.38N/AN/A-0.80xN/A0.08x0.17xN/A-$5.00M-1,091.51%$3.15M16.35-$1.64MN/A
ISPC
ISPECIMEN INC
$0.28N/AN/A-0.22xN/A0.25x0.26xN/A-$10.55M-422.83%$9.74M1.08$360.72k-0.04
BIAF
BIOAFFINITY TECHNOLOGIES INC
$1.97N/AN/A-2.16xN/A6.79x4.67xN/A-$6.06M-35.18%$4.86M0.56$21.44M-2.81
ILMN
ILLUMINA INC
$118.98N/AN/A-14.60x20.48x4.21x3.31xN/A$366.00M1.93%$5.73B36.06$20.04B-31.31
PMD
PSYCHEMEDICS CORP
$2.54N/AN/A-3.53xN/A0.66x2.19xN/A-$1.64M-11.22%$6.67M1.16$14.92M-19.43
TRIB
TRINITY BIOTECH PLC
$1.73N/AN/A-0.54xN/A0.23x-0.55xN/A-$14.57M-109.88%-$23.95M-3.12$77.00M-6.85
MYNZ
MAINZ BIOMED NV
$0.74N/AN/A-0.46xN/A13.45x4.82xN/A-$23.84M-198.38%$3.25M0.20$14.98M-0.61
MMA
ALTA GLOBAL GROUP LTD
$3.27N/AN/A-0.62xN/A21.80xN/AN/A-$5.92M-17.71%-$69.50M-6.80N/AN/A
CNTG
CENTOGENE NV
$0.45N/AN/A-0.29xN/A0.23x-0.75xN/A-$28.26M-227.56%-$16.55M-0.60$62.15M-1.40
TTOO
T2 BIOSYSTEMS INC
$3.63N/AN/A-0.32xN/A2.58x-0.85xN/A-$46.95M-253.86%-$37.77M-7.41$74.66M-1.93

Diagnostic & Research Stocks FAQ

What are the best diagnostic & research stocks to buy right now in May 2024?

According to Zen Score, the 3 best diagnostic & research stocks to buy right now are:

1. Fonar (NASDAQ:FONR)


Fonar (NASDAQ:FONR) is the top diagnostic & research stock with a Zen Score of 47, which is 20 points higher than the diagnostic & research industry average of 27. It passed 14 out of 33 due diligence checks and has strong fundamentals. Fonar has seen its stock return 6.6% over the past year, overperforming other diagnostic & research stocks by 5 percentage points.

2. Icon (NASDAQ:ICLR)


Icon (NASDAQ:ICLR) is the second best diagnostic & research stock with a Zen Score of 47, which is 20 points higher than the diagnostic & research industry average of 27. It passed 15 out of 33 due diligence checks and has strong fundamentals. Icon has seen its stock return 66.03% over the past year, overperforming other diagnostic & research stocks by 64 percentage points.

Icon has an average 1 year price target of $344.38, an upside of 9.28% from Icon's current stock price of $315.14.

Icon stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 8 analysts covering Icon, 75% have issued a Strong Buy rating, 25% have issued a Buy, 0% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

3. Star Equity Holdings (NASDAQ:STRR)


Star Equity Holdings (NASDAQ:STRR) is the third best diagnostic & research stock with a Zen Score of 46, which is 19 points higher than the diagnostic & research industry average of 27. It passed 18 out of 38 due diligence checks and has strong fundamentals. Star Equity Holdings has seen its stock return 8.24% over the past year, overperforming other diagnostic & research stocks by 7 percentage points.

What are the diagnostic & research stocks with highest dividends?

Out of 7 diagnostic & research stocks that have issued dividends in the past year, the 3 diagnostic & research stocks with the highest dividend yields are:

1. Qiagen Nv (NYSE:QGEN)


Qiagen Nv (NYSE:QGEN) has an annual dividend yield of 3.01%, which is 2 percentage points higher than the diagnostic & research industry average of 1.37%.

Qiagen Nv's dividend payout ratio of 87.2% indicates that its dividend yield is sustainable for the long-term.

2. Quest Diagnostics (NYSE:DGX)


Quest Diagnostics (NYSE:DGX) has an annual dividend yield of 2.12%, which is 1 percentage points higher than the diagnostic & research industry average of 1.37%. Quest Diagnostics's dividend payout is stable, having never dropped by more than 10% in the last 10 years. Quest Diagnostics's dividend has shown consistent growth over the last 10 years.

Quest Diagnostics's dividend payout ratio of 38.2% indicates that its dividend yield is sustainable for the long-term.

3. Laboratory Of America Holdings (NYSE:LH)


Laboratory Of America Holdings (NYSE:LH) has an annual dividend yield of 1.43%, which is the same as the diagnostic & research industry average of 1.37%. Laboratory Of America Holdings's dividend payout is stable, having never dropped by more than 10% in the last 10 years. Laboratory Of America Holdings's dividend has not shown consistent growth over the last 10 years.

Laboratory Of America Holdings's dividend payout ratio of 56.5% indicates that its dividend yield is sustainable for the long-term.

Why are diagnostic & research stocks up?

Diagnostic & research stocks were up 0.47% in the last day, and down -0.04% over the last week.

We couldn't find a catalyst for why diagnostic & research stocks are up.

What are the most undervalued diagnostic & research stocks?

Based on WallStreetZen's Valuation Score, the 3 most undervalued diagnostic & research stocks right now are:

1. Star Equity Holdings (NASDAQ:STRR)


Star Equity Holdings (NASDAQ:STRR) is the most undervalued diagnostic & research stock based on WallStreetZen's Valuation Score. Star Equity Holdings has a valuation score of 71, which is 53 points higher than the diagnostic & research industry average of 18. It passed 5 out of 7 valuation due diligence checks.

Star Equity Holdings's stock has gained 8.24% in the past year. It has overperformed other stocks in the diagnostic & research industry by 7 percentage points.

2. Enzo Biochem (NYSE:ENZ)


Enzo Biochem (NYSE:ENZ) is the second most undervalued diagnostic & research stock based on WallStreetZen's Valuation Score. Enzo Biochem has a valuation score of 71, which is 53 points higher than the diagnostic & research industry average of 18. It passed 5 out of 7 valuation due diligence checks.

Enzo Biochem's stock has dropped -57.87% in the past year. It has underperformed other stocks in the diagnostic & research industry by -59 percentage points.

3. Fonar (NASDAQ:FONR)


Fonar (NASDAQ:FONR) is the third most undervalued diagnostic & research stock based on WallStreetZen's Valuation Score. Fonar has a valuation score of 71, which is 53 points higher than the diagnostic & research industry average of 18. It passed 5 out of 7 valuation due diligence checks.

Fonar's stock has gained 6.6% in the past year. It has overperformed other stocks in the diagnostic & research industry by 5 percentage points.

Are diagnostic & research stocks a good buy now?

50% of diagnostic & research stocks rated by analysts are a strong buy right now. On average, analysts expect diagnostic & research stocks to rise by 10.22% over the next year.

What is the average p/e ratio of the diagnostics & research industry?

The average P/E ratio of the diagnostics & research industry is 38.56x.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.